US2008261914A1PendingUtilityA1

Stabilization of vitamin b12

52
Assignee: BAYER HEALTHCARE AGPriority: Mar 16, 2007Filed: Mar 11, 2008Published: Oct 23, 2008
Est. expiryMar 16, 2027(~0.6 yrs left)· nominal 20-yr term from priority
Inventors:Iris HeepHans-Rolf Taterra
A61P 43/00A61P 7/00A61P 3/02A61K 9/0019A61K 31/662A61K 31/66A61K 47/10A61K 31/714
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to preparations comprising vitamin B 12 and a butanol, and to the use of butanol for stabilizing vitamins.

Claims

exact text as granted — not AI-modified
1 . Preparation comprising vitamin B 12  and butanol. 
     
     
         2 . Preparation according to  claim 1 , characterized in that it is liquid. 
     
     
         3 . Preparation according to  claim 1 , characterized in that the butanol is selected from: n-butanol or isobutanol. 
     
     
         4 . Preparation according to  claim 1 , comprising n-butanol. 
     
     
         5 . Preparation according to  claim 1 , which additionally comprises a pharmacologically acceptable phosphonic acid derivative. 
     
     
         6 . Preparation according to any of  claims 1 , comprising a pharmacologically acceptable phosphonic acid derivative selected from butaphosphan and toldimfos. 
     
     
         7 . Preparation according to  claim 5 , comprising a pharmacologically acceptable phosphonic acid derivative selected from butaphosphan. 
     
     
         8 . Use of a preparation according to  claim 1  for the manufacture of a medicament. 
     
     
         9 . Use of butanol for stabilizing vitamin B 12 . 
     
     
         10 . Use of butanol for producing preparations of vitamin B 12  with improved vitamin B 12  stability.

Join the waitlist — get patent alerts

Track US2008261914A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.